The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Technetium-99m methoxyisobutyl isonitrile (RP30) for quantification of myocardial ischemia and reperfusion in dogs.
Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(9):1539-48.
This study was done to determine whether [99mTc]methoxyisobutyl isonitrile (RP30), a nonredistributing myocardial perfusion agent, could be used to quantify regional myocardial blood flow distribution during ischemia and reperfusion, employing sequential injections of tracer, tomographic imaging, and appropriate image subtraction. Dogs underwent transient (6 min) coronary artery occlusion, followed by two paired injections of RP30 and radioactive microspheres combined with tomographic imaging, the first during coronary occlusion and the second after 60 min of reperfusion. To obtain a true image representative of reperfusion, the first set of images was corrected for 99mTc decay and subtracted from the second. During occlusion, tissue microsphere content and scintigraphic RP30 activity in the center of the ischemic region (both expressed as a fraction of the nonischemic region) were closely correlated, although RP30 consistently exceeded microsphere content (0.43 +/- 0.03 vs. 0.24 +/- 0.04, p less than 0.01). Direct tissue counting of RP30 confirmed its relative excess in ischemic myocardium. Reperfusion was successful in 7/8 dogs, with an increase in RP30 activity to 0.98 +/- 0.04 compared to 0.89 +/- 0.03 for microspheres (p = N.S.). In one dog with microsphere-documented persistent ischemia, the RP30 defect was still present after reflow. Our results indicate that because of the lack of myocardial clearance and redistribution, repeat injections of RP30 can be used to quantify serial changes in regional myocardial blood flow.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Q S Li; G Solot; T L Frank; H N Wagner; L C BeckerJournal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(6):1069-76.
Dara L Kraitchman; Smita Sampath; Ernesto Castillo; John A Derbyshire; Raymond C Boston; David A Bluemke; Bernhard L Gerber; Jerry L Prince; Nael F OsmanCirculation 2003;107(15):2025-30.
M S Verani; M O Jeroudi; J J Mahmarian; T M Boyce; S Borges-Neto; B Patel; R BolliJournal of the American College of Cardiology 1988;12(6):1573-81.
Appears in this Publication
Author of this Publication